ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Natera Recognized on U.S. News & World Report’s 2024 Best Companies to Work for in Healthcare Ranking

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has been named by U.S. News & World Report as one of the best companies to work for in healthcare.

Natera was ranked among 349 companies across 20 fields of work on factors contributing to job seekers’ decision-making when choosing a workplace that best meets their needs in their industries of interest. In healthcare specifically, Natera earned a spot on the industry list alongside companies across different elements of healthcare operations and services, including biotechnology, life sciences, pharmaceuticals, and hospital operations.

“At Natera, we are committed to fostering a positive workplace environment where employees can learn from one another, further develop in their careers, and continue to thrive – all while contributing to our very important mission,” said Steve Chapman, chief executive officer of Natera. “Natera is a great place to work because of our extremely talented employees, and we are proud to earn a spot on this list alongside so many esteemed companies across different dimensions of healthcare.”

This new recognition by U.S. News expands on the general 2023-2024 U.S. News Best Companies to Work For list by looking at how companies measure up to the expectations of their employees within their respective industries. The rankings take into account quality of pay, work-life balance, and opportunities for professional development and advancement by industry.

To calculate the U.S. News Best Companies to Work For by Industry lists, U.S. News only considered companies that were a part of the Russell 3000 index as of June 2023 and scored in the top 20% of their industry. Additionally, U.S. News required each company to have a minimum of 75 Glassdoor reviews written between 2020-2022 and grouped companies according to the Industry Classification Benchmark (ICB) used by the FTSE Russell.

To learn more about career opportunities at Natera and the core values that define company culture, please visit: www.natera.com/company/careers/.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 150 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.